2018 to 2024 saw rise in insurance denials for brand-name drugs

3 months ago 10
Insurance denials of archetypal attempts to capable brand-name medicine drugs with nary generic competitors accrued by much than two-thirds from 2018 to 2024, according to a survey published online successful the Journal of the American Medical Association.
Read Entire Article